Abstract:The reaction of the vanadyl ion (VO2+) with imidazole-4-carboxylic acid (Im4COOH), imidazole-2-carboxylic acid (Im2COOH) and methylimidazole-2-carboxylic acid (MeIm2COOH), respectively, in the presence of small bioligands (bL) [oxalate (Ox), lactate (Lact), citrate (Cit) and phosphate (Phos)] and high-molecular-weight (HMW) human serum proteins [albumin (HSA) and transferrin (hTf)] were studied in aqueous solution using potentiometric acid–base titrations. The species distribution diagrams for the high-molecular-mass (HMM) proteins with oxidovanadium(IV) under physiological pH were dominated by VO(HMM)2, VOL(HMM) for unsubstituted ligands (L− = Im4COO− and Im2COO−). However, for the N-substituted MeIm2COOH, the species distribution diagrams under physiological pH were dominated by VOL2, VO(HMM)2 and VO2L2(HMM). These species were further confirmed by LC-MS, MALDI-TOF-MS and EPR studies. The glucose-stimulated insulin secretion (GSIS) action of the complexes was investigated using INS-1E cells at a 1 μM concentration, which was established through cytotoxicity studies via the MTT assay. The neutral complexes, especially VO(MeIm2COO)2, showed promising results in the stimulation of insulin secretion than the cationic [VO(MeIm2CH2OH)2]2+ complex and the vanadium salt. Oxidovanadium(IV) complexes reduced insulin stimulation significantly under normoglycaemic levels but showed positive effects on insulin secretion under hyperglycaemic conditions (33.3 mM glucose media). The islets exposed to oxidovanadium(IV) complexes under hyperglycaemic conditions displayed a significant increase in the stimulatory index with 1.19, 1.75, 1.53, 1.85, 2.20 and 1.29 observed for the positive control (sulfonylurea:gliclazide), VOSO4, VO(Im4COO)2, VO(Im2COO)2, VO(MeIm2COO)2 and VO(MeIm2CH2OH)22+, respectively. This observation showed a potential further effect of vanadium complexes towards type 2 diabetes and has been demonstrated for the first time in this study.

Synthesis, characterization and anti-diabetic therapeutic potential of novel aminophenol-derivatized nitrilotriacetic acid vanadyl complexes

Synthesis And Anti-Diabetic Activity Of New N,N-Dimethylphenylenediamine-Derivatized Nitrilotriacetic Acid Vanadyl Complexes

Synthesis, Characterization and Anti-Diabetic Therapeutic Potential of a New Benzyl Acid-Derivatized Kojic Acid Vanadyl Complex

The Molecular Mechanisms and Rational Design of Anti-Diabetic Vanadium Compounds.

Synthesis, Crystal Structures and Insulin-Like Activity of Two New Oxidovanadium(v) Complexes with Aroylhydrazones and Maltol Mixed-Ligands

Synthesis, Structures and Insulin-Like Activity of Oxidovanadium(v) Complexes with Aroylhydrazones and Ethylmaltol Mixed-Ligands

Insulin-enhancing Activity of a Dinuclear Vanadium Complex: 5-Chloro-salicylaldhyde Ethylenediamine Oxovanadium(v) and Its Permeability and Cytotoxicity.

Vanadium Complexes with Thioanilide Derivatives of Amino Acids: Inhibition of Human Phosphatases and Specificity in Various Cell Models of Metabolic Disturbances

A Non-Toxic Binuclear Vanadium(IV) Complex as Insulin Adjuvant Improves the Glycemic Control in Streptozotocin-Induced Diabetic Rats

Hydrazone-flavonol based oxidovanadium( V ) complexes: Synthesis, characterization and antihyperglycemic activity of chloro derivative in vivo

Vanadium Compounds Modulate PPARγ Activity Primarily by Increasing PPARγ Protein Levels in Mouse Insulinoma NIT-1 Cells

Vanadyl Acetylacetonate Upregulates PPARγ and Adiponectin Expression in Differentiated Rat Adipocytes

Bis(acetylacetonato)-oxovanadium(iv), bis(maltolato)-oxovanadium(iv) and sodium metavanadate induce antilipolytic effects by regulating hormone-sensitive lipase and perilipin via activation of Akt.

A New Insulin-Enhancing Agent: [N,N '-Bis(4-Hydroxysalicylidene)-O-Phenylene-Diamine]Oxovanadium(Iv) And Its Permeability And Cytotoxicity

Vanadium compounds: New potential antidiabetic drugs

Synthesis of Novel Β-Amino Ketones Containing a P -Aminobenzoic Acid Moiety and Evaluation of Their Antidiabetic Activities

Biospeciation of Oxidovanadium(IV) Imidazolyl–Carboxylate Complexes and Their Action on Glucose-Stimulated Insulin Secretion in Pancreatic Cells

Effect of the Chloro-Substitution on Lowering Diabetic Hyperglycemia of Vanadium Complexes with Their Permeability and Cytotoxicity.

Anti-diabetic Vanadyl Complexes Reduced Alzheimer’s Disease Pathology Independent of Amyloid Plaque Deposition

3,4-Dihydroxyphenethyl nitrate with nitric oxide releasing, antioxidant, hypoglycemic and hypolipidemic effects

The Anti-Diabetic Effects and Pharmacokinetic Profiles of Bis(maltolato)oxovanadium in Non-Diabetic and Diabetic Rats.